<DOC>
	<DOCNO>NCT01503424</DOCNO>
	<brief_summary>The purpose study compare bioequivalence characterize profile olanzapine tablet , 5 mg zyprexa tablet , 5 mg healthy , adult , human subject feed condition monitor adverse event ensure safety subject .</brief_summary>
	<brief_title>Bioequivalence Study Olanzapine Tablets , 5 mg Under Fed Study</brief_title>
	<detailed_description>An open label , balance , randomize , two-treatment , two-period , two-sequence , single oral dose , crossover , bioequivalence study Olanzapine Tablets 5 mg Dr. Reddy 's Laboratories Limited , India , compare Zyprexa® ( Olanzapine ) Tablets 5 mg Eli Lilly Company , USA , healthy , adult , human subject feed condition .</detailed_description>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Healthy , adult , human volunteer 18 45 year age ( inclusive ) live around Ahmedabad city western part IndIa . Having Body Mass Index ( BMI ) 18.5 24.9 ( inclusive ) , calculate weight kg/height m2 . Nonsmokers since least six month . Have significant disease clinically significant abnormal finding screen , medical history , clinical examination , laboratory evaluation , 12 lead ECG Xray chest ( posteroanterior view ) recording . Able understand comply study procedure . opinion Principal investigator . Able give voluntary write informed consent participation trial . In case female subject : Surgically sterilize least 6 month prior study participation If child bear potential willing use suitable effective double barrier contraceptive method intra uterine device study . Pregnancy test must negative . Known hypersensitivity idiosyncratic reaction olanzapine excipients drug substance . History presence disease condition might compromise haemopoietic , renal , hepatic , endocrine , pulmonary , central nervous , cardiovascular , immunological , dermatological , gastrointestinal body system . A recent history harmful use alcohol ( less 2 year ) , ie alcohol consumption 14 standard drink per week men 07 standard drink per week woman ( A standard drink define 360 ml beer 150 ml wine 45 ml 40 % distilled spirit rum , whisky , brandy etc ) , consumption alcohol alcoholic product within 48 hrs prior receive IMP . Inability remain upright position time dose . Sitting blood pressure le 110/70 mm Hg pulse rate le 60 100 beat per minute time screen . Presence orthostatic hypotension time screen . Ingestion Use medication time within l4 day prior dose period1 . In case subject selection discretion Principal Investigator . Any history presence asthma ( include aspirin induce asthma ) nasal polyp NSAII ) induce urticaria . Consumption Grape fruit product within period 48 hour prior receive study drug . The presence clinically significant abnormal laboratory value screen . Use recreational drug history drug addiction test positive prestudy drug scan . History presence psychiatric disorder . A history difficulty donate blood . Donation blood ( l unit 350 mL ) receipt investigational medicinal product participation drug research study within period 90 day prior first dose study medication . Elimination halflife study drug take consideration inclusion subject study . Note : In case blood loss ≤ 200 mL ; subject may enrol 60 day blood donation last sample previous study . A positive hepatitis screen include hepatitis B surface antigen HCV antibody . A positive test result HIV antibody . An unusual diet , whatever reason ( e.g . lowsodium ) , four week prior receive study drug . In case subject selection discretion Principal Investigator . Nursing mother ( female ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>